Review



primary human brain microvascular endothelial cells (hbmecs; acbri376)  (Cell Systems Corporation)

 
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 90

    Structured Review

    Cell Systems Corporation primary human brain microvascular endothelial cells (hbmecs; acbri376)
    Primary Human Brain Microvascular Endothelial Cells (Hbmecs; Acbri376), supplied by Cell Systems Corporation, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/primary human brain microvascular endothelial cells (hbmecs; acbri376)/product/Cell Systems Corporation
    Average 90 stars, based on 1 article reviews
    primary human brain microvascular endothelial cells (hbmecs; acbri376) - by Bioz Stars, 2026-03
    90/100 stars

    Images



    Similar Products

    90
    Cell Systems Corporation primary human brain microvascular endothelial cells (hbmecs; acbri376)
    Primary Human Brain Microvascular Endothelial Cells (Hbmecs; Acbri376), supplied by Cell Systems Corporation, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/primary human brain microvascular endothelial cells (hbmecs; acbri376)/product/Cell Systems Corporation
    Average 90 stars, based on 1 article reviews
    primary human brain microvascular endothelial cells (hbmecs; acbri376) - by Bioz Stars, 2026-03
    90/100 stars
      Buy from Supplier

    90
    Cell Systems Corporation primary hbmec acbri376
    <t>Cultured</t> <t>HBMEC</t> monolayer treated with HG-IL1β was used to mimic BBB injury under diabetic conditions. The monolayer was then treated with rFGF21 and the permeability was measured. (A) IL-1β protein level in diabetic mice brain measured by Western blot (* p<0.05 vs. db/+, n=4); (B) Viability of cultured HBMEC after treatment with HG-IL1β and rFGF21; (C) Relative HBMEC monolayer permeability after treatment with HG-IL1β and rFGF21 (* p<0.05 vs. norm; # p<0.05 vs. HG-IL1β; n=6); (D) Representative western blot images of junction protein expression in cultured HBMEC after HG-IL1β and rFGF21 treatment; (E, F, G) Quantification of junction protein ZO-1, VE-cadherin and Occludin in cultured HBMEC (*p<0.05 vs. norm; # p<0.05 vs. HG-IL1β; n=6); (H) Immunocytochemistry of ZO-1 and VE-cadherin in cultured HBMEC after HG-IL1β and rFGF21 treatment.
    Primary Hbmec Acbri376, supplied by Cell Systems Corporation, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/primary hbmec acbri376/product/Cell Systems Corporation
    Average 90 stars, based on 1 article reviews
    primary hbmec acbri376 - by Bioz Stars, 2026-03
    90/100 stars
      Buy from Supplier

    90
    Cell Systems Corporation primary hbmecs acbri376
    <t>Cultured</t> <t>HBMEC</t> monolayer treated with HG-IL1β was used to mimic BBB injury under diabetic conditions. The monolayer was then treated with rFGF21 and the permeability was measured. (A) IL-1β protein level in diabetic mice brain measured by Western blot (* p<0.05 vs. db/+, n=4); (B) Viability of cultured HBMEC after treatment with HG-IL1β and rFGF21; (C) Relative HBMEC monolayer permeability after treatment with HG-IL1β and rFGF21 (* p<0.05 vs. norm; # p<0.05 vs. HG-IL1β; n=6); (D) Representative western blot images of junction protein expression in cultured HBMEC after HG-IL1β and rFGF21 treatment; (E, F, G) Quantification of junction protein ZO-1, VE-cadherin and Occludin in cultured HBMEC (*p<0.05 vs. norm; # p<0.05 vs. HG-IL1β; n=6); (H) Immunocytochemistry of ZO-1 and VE-cadherin in cultured HBMEC after HG-IL1β and rFGF21 treatment.
    Primary Hbmecs Acbri376, supplied by Cell Systems Corporation, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/primary hbmecs acbri376/product/Cell Systems Corporation
    Average 90 stars, based on 1 article reviews
    primary hbmecs acbri376 - by Bioz Stars, 2026-03
    90/100 stars
      Buy from Supplier

    Image Search Results


    Cultured HBMEC monolayer treated with HG-IL1β was used to mimic BBB injury under diabetic conditions. The monolayer was then treated with rFGF21 and the permeability was measured. (A) IL-1β protein level in diabetic mice brain measured by Western blot (* p<0.05 vs. db/+, n=4); (B) Viability of cultured HBMEC after treatment with HG-IL1β and rFGF21; (C) Relative HBMEC monolayer permeability after treatment with HG-IL1β and rFGF21 (* p<0.05 vs. norm; # p<0.05 vs. HG-IL1β; n=6); (D) Representative western blot images of junction protein expression in cultured HBMEC after HG-IL1β and rFGF21 treatment; (E, F, G) Quantification of junction protein ZO-1, VE-cadherin and Occludin in cultured HBMEC (*p<0.05 vs. norm; # p<0.05 vs. HG-IL1β; n=6); (H) Immunocytochemistry of ZO-1 and VE-cadherin in cultured HBMEC after HG-IL1β and rFGF21 treatment.

    Journal: Molecular neurobiology

    Article Title: Recombinant FGF21 protects against blood-brain barrier leakage through Nrf2 upregulation in type 2 diabetes mice

    doi: 10.1007/s12035-018-1234-2

    Figure Lengend Snippet: Cultured HBMEC monolayer treated with HG-IL1β was used to mimic BBB injury under diabetic conditions. The monolayer was then treated with rFGF21 and the permeability was measured. (A) IL-1β protein level in diabetic mice brain measured by Western blot (* p<0.05 vs. db/+, n=4); (B) Viability of cultured HBMEC after treatment with HG-IL1β and rFGF21; (C) Relative HBMEC monolayer permeability after treatment with HG-IL1β and rFGF21 (* p<0.05 vs. norm; # p<0.05 vs. HG-IL1β; n=6); (D) Representative western blot images of junction protein expression in cultured HBMEC after HG-IL1β and rFGF21 treatment; (E, F, G) Quantification of junction protein ZO-1, VE-cadherin and Occludin in cultured HBMEC (*p<0.05 vs. norm; # p<0.05 vs. HG-IL1β; n=6); (H) Immunocytochemistry of ZO-1 and VE-cadherin in cultured HBMEC after HG-IL1β and rFGF21 treatment.

    Article Snippet: Primary HBMEC was obtained from Cell Systems Corporation (ACBRI376, Kirkland, WA), and cultured in complete growth media EBM-2 containing supplements growth factors (Lonza, Walkersville, MD).

    Techniques: Cell Culture, Permeability, Western Blot, Expressing, Immunocytochemistry

    The FGFR1 inhibitor, PD173074, was used to examine the roles of FGFR1 in BBB protection effect by FGF21 using cultured HBMEC monolayer. (A) Relative permeability of HBMEC monolayer after HG-IL1β and FGF21 treatment with or without PD173074; (B) Representative Western Blot images to measure FGFR1, pFGFR1 and β-Klotho in cultured HBMEC after HG-IL1β and FGF21 treatment with or without PD173074; (C) Quantification of pFGFR1 in cultured HBMEC. (* p<0.05 vs. HG-IL1β; #p<0.05 vs. HG-IL1β+F21; n=4).

    Journal: Molecular neurobiology

    Article Title: Recombinant FGF21 protects against blood-brain barrier leakage through Nrf2 upregulation in type 2 diabetes mice

    doi: 10.1007/s12035-018-1234-2

    Figure Lengend Snippet: The FGFR1 inhibitor, PD173074, was used to examine the roles of FGFR1 in BBB protection effect by FGF21 using cultured HBMEC monolayer. (A) Relative permeability of HBMEC monolayer after HG-IL1β and FGF21 treatment with or without PD173074; (B) Representative Western Blot images to measure FGFR1, pFGFR1 and β-Klotho in cultured HBMEC after HG-IL1β and FGF21 treatment with or without PD173074; (C) Quantification of pFGFR1 in cultured HBMEC. (* p<0.05 vs. HG-IL1β; #p<0.05 vs. HG-IL1β+F21; n=4).

    Article Snippet: Primary HBMEC was obtained from Cell Systems Corporation (ACBRI376, Kirkland, WA), and cultured in complete growth media EBM-2 containing supplements growth factors (Lonza, Walkersville, MD).

    Techniques: Cell Culture, Permeability, Western Blot

    The involvement of Nrf2 in FGF21 protection for BBB was examined using db/db mice and cultured HBMEC monolayer. (A) Nrf2 and pNrf2 protein levels measured by Western blot in nuclear extract of db/db mice brain after rFGF21 treatment (* p<0.05 vs. db/+; # p<0.05 vs. db/db; n=4); (B) Nrf2 and pNrf2 protein levels measured by Western blot in cultured HBMEC after HG-IL1β and rFGF21 treatment (* p<0.05 vs. norm; # p<0.05 vs. HG-IL1β; n=3). (C) Relative HBMEC monolayer permeability after treatment with HG-IL1β and rFGF21, with or without Trigonelline, the Nrf2 inhibitor (* p<0.05 vs. norm; # p<0.05 vs. HG-IL1β; & p<0.05 vs. HG-IL1β+F21; n=4). The roles of Nrf2-Keap1 interaction in BBB protection by FGF21 was further investigated using db/db mice and cultured HBMEC. (D) Representative Western blot images and quantification for Keap1 protein in db/db mice brain after FGF21 treatment; (E) Representative Western blot images and quantification for Nrf2 and pNrf2 detection after Co-IP with Keap1 antibody using the brain lysate of db/db mice after rFGF21 treatment (* p<0.05 vs. db/+; # p<0.05 vs. db/db; n=4). Keap1 and Nrf2 interaction was also measured in cultured HBMEC after HG-ΙL1β and rFGF21 treatment. (F) Keap1 Western blot and quantification in cultured HBMCE; (G) Co-IP was performed using Keap1 antibody with HBMCE lysate, and pNrf2 in the precipitate was assessed using Western blot (* p<0.05 vs. norm; # p<0.05 vs. HG- IL1β; n=3). (H) Representative Western blot images of Smad2, p-Smad2 and Snail in db/db mice after rFGF21 treatment.

    Journal: Molecular neurobiology

    Article Title: Recombinant FGF21 protects against blood-brain barrier leakage through Nrf2 upregulation in type 2 diabetes mice

    doi: 10.1007/s12035-018-1234-2

    Figure Lengend Snippet: The involvement of Nrf2 in FGF21 protection for BBB was examined using db/db mice and cultured HBMEC monolayer. (A) Nrf2 and pNrf2 protein levels measured by Western blot in nuclear extract of db/db mice brain after rFGF21 treatment (* p<0.05 vs. db/+; # p<0.05 vs. db/db; n=4); (B) Nrf2 and pNrf2 protein levels measured by Western blot in cultured HBMEC after HG-IL1β and rFGF21 treatment (* p<0.05 vs. norm; # p<0.05 vs. HG-IL1β; n=3). (C) Relative HBMEC monolayer permeability after treatment with HG-IL1β and rFGF21, with or without Trigonelline, the Nrf2 inhibitor (* p<0.05 vs. norm; # p<0.05 vs. HG-IL1β; & p<0.05 vs. HG-IL1β+F21; n=4). The roles of Nrf2-Keap1 interaction in BBB protection by FGF21 was further investigated using db/db mice and cultured HBMEC. (D) Representative Western blot images and quantification for Keap1 protein in db/db mice brain after FGF21 treatment; (E) Representative Western blot images and quantification for Nrf2 and pNrf2 detection after Co-IP with Keap1 antibody using the brain lysate of db/db mice after rFGF21 treatment (* p<0.05 vs. db/+; # p<0.05 vs. db/db; n=4). Keap1 and Nrf2 interaction was also measured in cultured HBMEC after HG-ΙL1β and rFGF21 treatment. (F) Keap1 Western blot and quantification in cultured HBMCE; (G) Co-IP was performed using Keap1 antibody with HBMCE lysate, and pNrf2 in the precipitate was assessed using Western blot (* p<0.05 vs. norm; # p<0.05 vs. HG- IL1β; n=3). (H) Representative Western blot images of Smad2, p-Smad2 and Snail in db/db mice after rFGF21 treatment.

    Article Snippet: Primary HBMEC was obtained from Cell Systems Corporation (ACBRI376, Kirkland, WA), and cultured in complete growth media EBM-2 containing supplements growth factors (Lonza, Walkersville, MD).

    Techniques: Cell Culture, Western Blot, Permeability, Co-Immunoprecipitation Assay